AquaBounty Technologies, Inc. (AQB)

Market Cap	55.52M
Revenue (ttm)	2.91M
Net Income (ttm)	-23.58M
Shares Out	71.11M
EPS (ttm)	-0.33
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	556,789
Open	0.758
Previous Close	0.716
Day's Range	0.716 - 0.808
52-Week Range	0.711 - 4.500
Beta	0.99
Analysts	Buy
Price Target	4.66 (+496.8%)
Earnings Date	Nov 2, 2022

About AQB

AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty...

• Industry: Biotechnology
• Founded: 1991
• CEO: Sylvia Wulf
• Employees: 103
• Stock Exchange: NASDAQ
• Ticker Symbol: AQB

Full Company Profile

Financial Performance

In 2021, AQB's revenue was $1.17 million, an increase of 820.26% compared to the previous year's $127,663. Losses were -$22.32 million, 36.1% more than in 2020.

Financial Statements

Analyst Forecast

According to 8 analysts, the average rating for AQB stock is "Buy." The 12-month stock price forecast is 4.66, which is an increase of 496.82% from the latest price.

Price Target

$4.66

(496.82% upside)

Analyst Consensus: Buy

Stock Forecasts